Skip to main content
. 2021 Oct 30;13(21):5466. doi: 10.3390/cancers13215466

Figure 3.

Figure 3

Monitoring of I-score according to responses in patients receiving chemotherapy. (a,b) The responses according to changes in I-score in 18 metastatic patients. At six months post-treatment, two patients with 37.2% or 9.6% increased I-score showed progressive disease (PD). In contrast, two (40%) of five patients with a 13.1% or 15.9% decrease in I-score showed progressive disease. (c) Case presentation with computerized tomography (CT) images.